Meropenem Infusion

DRUG3 trials

Sponsors

Unity Health Toronto, Pakistan Navy Station Shifa Hospital, Hellenic Institute for the Study of Sepsis

Conditions

Bacterial InfectionCystic Fibrosis Pulmonary ExacerbationSepsis

Phase 3

THE ROLE OF PANCREATIC STONE PROTEIN (PSP) AND PSP-GUIDED EARLY MEROPENEM TREATMENT TO MITIGATE SEPSIS RISK AT THE EMERGENCY DEPARTMENT: THE PROMISE DOUBLE BLIND, PHASE III, RANDOMIZED CONTROLLED CLINICAL TRIAL

Not yet recruitingNCT07813767

Hellenic Institute for the Study of SepsisSepsis

Start: 2026-09-01End: 2028-12-01Target: 398Updated: 2026-09-10

Phase 4

EFFICACY OF PROLONGED INFUSION MEROPENEM IN CRITICALLY ILL PAEDIATRIC INTENSIVE CARE PATIENTS

CompletedNCT07122596

Pakistan Navy Station Shifa HospitalSepsis, Bacterial Infection

Start: 2024-04-01End: 2024-08-31Updated: 2025-08-14

Unknown Phase

Pharmacokinetic Study of Extended Infusion Meropenem in Adult Cystic Fibrosis Patients

TerminatedNCT01158937

Unity Health TorontoCystic Fibrosis Pulmonary Exacerbation

Start: 2010-05-31End: 2014-01-31Updated: 2015-05-21